{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-26-010269","form_type":"8-K","ticker":"CLVT","cik":"0001764046","company_name":"CLARIVATE PLC","filed_at":"2026-07-06T21:00:42+00:00","discovered_at":"2026-07-06T21:02:00.303683+00:00","generated_at":"2026-07-06T21:02:05.689082+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clarivate sells Life Sciences & Healthcare business to Altaris for $600M","bullets":["Purchase price $600M: $500M cash at close, $25M deferred, $75M senior note.","Transaction expected to close by end of 2026; no shareholder vote required.","Buyer's termination fee of $33M guaranteed by Altaris funds.","Henry Levy, President of the business, gets retention agreement: RSU vesting, PSU cancellation, severance if terminated without cause within 6 months post-close."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-26-010269","json":"https://secwatch.observer/filing/0000950103-26-010269.json","markdown":"https://secwatch.observer/filing/0000950103-26-010269.md","text":"https://secwatch.observer/filing/0000950103-26-010269.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764046/000095010326010269/0000950103-26-010269-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764046/000095010326010269/dp249688_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-06T21:02:05.689082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}